Evaluation of the Benefits of a Pharmacist-led Educational Program on Achievement of Intra-ocular Pressure Target among Patients with Open Angle Glaucoma: A Qusai-experimental Study.

Save

ABSTRACT

Objectives:

To evaluate the effectiveness of a pharmacist-led educational program in achieving intraocular pressure (IOP) target, as well as in improving adherence and proficiency in eye drop administration techniques among glaucoma patients.

Methods:

This qusai experimental study was conducted at Ibn Al-Haytham Teaching Hospital, Baghdad, Iraq, including 94 adult patients diagnosed with primary open angle glaucoma. The intervention involved an educational program designed according to the Health Belief Model, focusing on enhancing glaucoma awareness, proper eye drop administration techniques, and strategies for improving adherence to therapy. Participants engaged in a 30–40 min individualized session, supplemented by educational materials.

Data on IOP, adherence using the Morisky Medication Adherence Scale-4, and administration techniques were collected pre- and post-intervention.

Findings:

A marked improvement was detected; adherence rates increased significantly from 2.86% to 11.43%, and the accuracy of drop administration improved from 14.29% to 57.14%. In addition, 51.43% of patients were able to achieve their IOP targets after the educational intervention. Statistical analyses revealed these enhancements were significant (P < 0.001), with no demographic or clinical factors correlating with the efficacy of the program.

Conclusions:

This pilot study underscores the critical role of pharmacist-led education for patients with primary open-angle glaucoma in improving treatment outcomes, particularly in achieving IOP targets and therby reducing the risk of vision loss. Future research involving larger cohorts and longer follow-up is necessary to further validate these findings.

INTRODUCTION

As a preventable and irreversible cause of blindness, glaucoma necessitates increased attention and care for accurate diagnosis and management to avert such an outcome.[1] Elevated intraocular pressure (IOP) is the only adjustable risk factor for optic nerve injury. Reducing IOP to a level that prevents more optic nerve damage, referred to as the IOP target, is fundamental to glaucoma care.[2] Eye drops are the predominant treatment for glaucoma.[2] However, achievement of the IOP target by eye drops is poor among Iraqi glaucoma patients in which only 35% of them attain their IOP target.[3]

Indeed, to achieve maximum effect from eye drops and to attain IOP target, eye drops must be administered consistently and correctly.[4] Unfortunately, most Iraqi patients with glaucoma improperly administer their eye drops; moreover, they rarely adhere to their prescribed treatment.[5] These issues can largely be attributed to a lack of patient knowledge and awareness concerning glaucoma and its management. This gap in patients’ knowledge may stem from the limited involvement of Iraqi pharmacists in offering adequate patient counseling and education about their treatment.[678] A lack of consistent pharmacist involvement in patient counseling contributes to improper usage of eye drops, poor awareness, and adherence to treatment and ultimately poor clinical outcomes.[5] This problem highlighting the need to strengthen pharmacist role in educating glaucoma patients about their diseases and its treatment.

Educational interventions could significantly enhance glaucoma patients’ knowledge and understanding of the disease and its treatment, leading to better adherence, correct administration of eye drops, and ultimately improved overall treatment outcomes.[9] Several studies had been conducted in developed and developing countries to assess the effect of educational interventions for glaucoma patients;[101112] however, to the best of our knowledge, no studies have been undertaken in Iraq to execute and assess the effect of educational programs for glaucoma patients on enhancing their IOP target achievement. Consequently, the present study aimed to develop and evaluate the benefits of a pharmacist-led education program on achieving IOP target in glaucoma patients, as well as adherence and proficiency in eyedrop administration techniques.

METHODS

The educational program was developed with the aim to address the scientific gaps about medical therapy among Iraqi glaucoma patients (poor adherence and inaccurate eye drop administration). It was designed to provide information about glaucoma, its complications, the aims of its treatment, the appropriate technique for administering of eye drops, the essentiality of adherence to medical treatment plans, and tips to enhance medication adherence [Table 1]. To enhance patient acceptance of the information, they were delivered based on the health belief model, which has been found to be highly useful among Iraqi patients with chronic diseases.[1314] The outlines of the educational program are shown in Table 1.

Educational information of the program was obtained from relevant literature sources.[41516] To validate the educational contents of the program, all details were sent to a panel of experts (3 academic pharmacists with PhD degree in clinical pharmacy and one ophthalmologist). The experts were asked to provide their feedback on the accuracy and relevance of the scientific content of the program using a 3-point likert scale: Good, fair, and poor. All panel members considered the relevance and accuracy of the educational information as good.

The educational program was delivered by the first study author (a pharmacist currently enrolled as a Master’s candidate in clinical pharmacy). The first study author had received training on effective patient communication and information delivery from the second author, who holds a PhD in pharmacy practice. The programe was delivered to each patient in an indiviudal-basis through face-to-face interview.

The interviews were conducted in a quiet room at the hospital. Before providing the educational information, the responsible researcher checked the patient’s administration technique and adherence to eye drops, to be able to provide a more focused education on the areas of greatest need. The educational interviews included open discussions, posters, and real demonstrations.

Upon finishing the session, each patient was asked to provide a feedback about the main educational points.

The educational session took about 30–40 min. Each participant was provided with an educational brochure at the end of the session. The details of the educational program are illustrated in Table 1.

A quasi-experimental (pre-post) study was carried out on a convenient sample of patients with open-angle glaucoma at Ibn-Al-Haytham Hospital, Baghdad, Iraq, to assess the benefits of the developed educational program. This study was ethically approved by the ethical committee at the College of Pharmacy – University of Baghdad (Approval Number: RECA4BCP10112023 at 10/11/2023).

Adults with confirmed diagnosis of an open-angle glaucoma by an ophthalmologist and already on medical therapy (using eye drops) for at least 1 month and not more than 1 year, and who are Arabic speakers, were eligible to participate in this study. Meanwhile, patients who achieved their IOP target, patients in whom the IOP target could not be determined (i.e., those with unknown and/or undocumented IOP readings at the time of initial diagnosis), patients with a history of psychiatric disorders, patients prescribed additional anti-glaucoma medications at the time of study inclusion, and patients who experienced a change in their glaucoma medication dosage were excluded from this study. In addition, patients who were newly prescribed eye drops (<1 month) were also excluded to avoid the bias from their lack of familiarity.

Similarly, those on treatment for over a year were excluded, as their stable glaucoma could result in false-negative results for the educational program.

To calculate the required sample size to achieve a statistical power of 80%, the following formula was used:[17]

n = [(Zα/2+Zβ)2(p1(1-p1)+p2(1-p2)/(p2-p1)2

Where n is the required sample size per group; p1 is the expected proportion at baseline which is assumed to be 35% based on previous studies in Iraq;[35] p2 is the expected proportion after the intervention; assumed to be 55%. Therefore, the required sample size was 94.

Glaucoma patients were approached in the waiting rooms while they waited for their appointment. All eligible patients were informed about the study objectives and only those who provided their verbal informed consent will be included in the study. All included patients were receiving a pharmacist-led-education and were followed-up for 1 month after the completion of the educational session.

Enrollment of the study sample was accomplished during the period from December 2023 to August 2024.

Patient demographics, the duration of glaucoma, the prescribed medications (eye drops), and the history of counseling about the prescribed treatment were collected at the start of the study during the initial interview with each participant. In addition, IOP values (primary outcome), measured by an ophthalmologist using a non-contact tonometer (NIDEK CO. LTD in Japan), were assessed at the day of enrollment in the study and at the study end and were documented for all included patients.

The effectiveness of medicinal therapy in achieving the IOP objective was evaluated using the percentage of IOP reduction. The drop in IOP is usually between 20% and 50% of the baseline level, depending on the stage of the disease. However, most clinicians thought a 30% reduction to be tolerable,[15] thus this was chosen as the study’s aim.

Furthermore, medication adherence and the eye drop administration technique were assessed twice, at time of enrolment and after 1 month of the educational session. Medication adherence was measured by using the Arabic version of the Morisky Medication Adherence Scale-4.[18] Due to the low educational level of some patients and poor visual acuity for most patients, the questionnaire was administered by the researcher through direct interview with each patient. Patients who scored 4 were considered to have good adherence, 2 or 3 to have fair adherence, and those who scored 1 or zero to have poor medication adherence.

The eye drop administration technique was assessed by the first study author through direct observation to each patient while putting a drop in his/her eyes. To accomplish this step, patients who already had eye drops with them and if the time was due for treatment, they were asked to use their eye drops in the demonstration. All other patients were given a single-use natural tear eye drop and then asked to put a drop in their eyes.[19] They were allowed to choose which eye they used minimising any potential influence of handedness on their performance.

In addition to direct observation, patients using more than one anti-glaucoma medication were asked to specify which medication they usually used first and the time between the administration of these medications.

Data observed during the assessment were immediately documented in a newly developed checklist [Appendix A] designed based on the previous literature.[1516] This checklist was validated by a panel of three experts in clinical pharmacy.

Because some patients using a single eye drop for treatment, and others were using multiple eye drops, the accuracy of the eye drop administration technique was calculated as a percentage; this was calculated by dividing the number of correct steps done by the patient by the total possible number of required steps for the optimum technique of eye drop administration. Patients who administered eye drops with an accuracy of 80% or more were considered to have good administration technique, those with 60%–80% were considered moderate, and those with less than 60% were considered poor.[20]

Data input and analysis were accomplished using the SPSS software version 16 (SPSS Inc., Chicago, IL, USA). Categorical variables were presented as number and frequencies. Continuous variables were presented as mean ± standard deviation.

The Chi-square test was used to assess the degree of difference between independent categorical variables; meanwhile, Fisher’s exact test was used when cell frequencies <5. McNemar test was used to measure the difference between dependent categorical variables. Shapiro–Wilk test was used to test the normality of distribution for continuous variables.

Paired t-test was used to measure the difference between dependent continuous data, while Wilcoxon rank test was used for abnormally distributed data. Independent t-test was used to measure the difference between independent continuous variables and the Mann–Whitney U-test was used to measure the difference between independent continuous variables.

Binary regression analysis was used to assess the infleunce of demographic (age and educational level) and clinical factors (baseline level of adherence to eye drops, baseline level of the accuracy of eye drop instillation technique, duration of glaucoma, and the number of used eye drops) on the benefits from the educational program in the achievement of IOP target. P <0.05 were considered significant.

RESULTS

Demographics of the study participants

A total of 94 patients were enrolled in this study, only 35 completed this study successfully [Figure 1].

The mean age of the patients involved in this study was 57.11 years. More than 70% (n = 25) of the participants were males. The majority of participants had either primary or intermediate level of education.

The monthly income for most study participants (54.29%, n = 19) ranged from 500,000 to 750,000 ID. All of the aforementioned demographics were not significantly different between those who completed the study and those who did not. Further details are presented in Table 2.

Clinical parameters of the study participants

The average duration of glaucoma among study participants was 12.29 ± 11.28 months. Nearly half of participants were using two eye drops. Before enrollment of patients in the educational program, adherence to eye drops was good for only 2.86% (n = 1) of participants and 60% (n = 21) of participants were poorly adherent.

Poor eye drop administration technique was detected in about 85% of the study participants. Only 2.86% (n = 1) of participating patients had received education about the usage of their eye drops. All of the aforementioned clinical parameters were not significantly different between those who completed the study and those who did not.

Further details are presented in Table 3.

The effect of pharmacist-led education on eyedrop adherence, accuracy of administration and achievement of intraocular pressure target

At the start of the study, 60% of participants were poorly adherent to their eye drops. Following the educational intervention, average adherence to eye drops, as measured by the Morisky score, nearly doubled from 1.31 ± 0.90 to 2.63 ± 1.00 (P < 0.001). In addition, the proportion of fully adherent participants increased from 2.86% to 11.43% (P < 0.001), while the percentage of poorly adherent participants decreased significantly from 60% to 8.57% (P < 0.001).

Further details are shown in Table 4.

At the start of the study, 85% of participants had poor technique for administering their eye drops. After the application of the educational intervention, the accuracy of eye drop administration technique significantly increased from 42.85 ± 13.71% to 77.04 ± 12.51% (P < 0.001). Moreover, the number of participants using a good technique rose significantly from 0% to 57.14%, while those with poor technique decreased significantly from 85.71% to 5.71% (P < 0.001) [Table 4].

At the start of the study, all of the enrolled participants failed to achieve their IOP target. After the application of the educational intervention, the IOP target was achieved in 51.43% of participants. The mean IOP for the right eye decreased from 23.03 mmHg to 18.29 mmHg (P < 0.001) and for the left eye from 23.32 mmHg to 18.18 mmHg (P < 0.001) [Table 4].

Factors influencing the benefits from the educational program in the achievement of intraocular pressure target

None of the studied parameters (age, baseline level of adherence to eye drops, baseline level of the accuracy of eye drop administration technique, duration of glaucoma, educational level, and the number of used eye drops) were significantly assocaited with the achievement of IOP target [Table 5].

DISCUSSION

The present study results showed that 51% were able to achieve their IOP target after joining the current educational program. This good achievement may be attributed to the enhancement effect of the educational program in the administration technique and adherence of patients to their eye drops.[21] Similarly, a study conducted in the Netherlands, found that the educational intervention was significantly effective in reducing the mean IOP for participating glaucoma patients.[22]

On the other hand, IOP value was reduced for participating patients who did not reach their IOP target; this small reduction in IOP is still clinically significant since it can delay glaucoma progression and safeguard vision.[23]

At the start of the study, most participating patients had poor adherence to their eye drops. This finding is similar to that detected in many other studies that conducted in Iraq and other developing countries.[52425]

The findings of the present study showed a substantial rise in the adherence level among study participants who attended the educational session. This finding aligns with the results observed from educational interventions aimed at improving eye drop adherence among glaucoma patients in Arab countries such as Jordan and Saudi Arabia.[1011] However, similar educational interventions have failed to increase adherence to eye drops among glaucoma patients in developed countries such as the United States and South Korea.[1226]

The discrepancies in the benefits of educational programs between patients living in developed and developing countries may stem from the poor knowledge and awareness of glaucoma and its treatment among patients in developing countries like Syria,[27] due to the low level of care and limited education available to these patients compared to those in developed countries;[28] thus, the effect of any educational intervention will be more significant for patients living in developing countries.

Regarding the accuracy of eye drop administration technique, the findings of the current study showed that the majority of the patients were poorly instilling their eye drops at the beginning of the study. This finding is very common among Iraqi patients with glaucoma.[5] A significant increase in the accuracy of eye drop administration technique was detected among participants who received the present educational intervention. A similar benefit was observed among glaucoma patients who attended educational interventional programs in developed and developing countries.[2129]

Although the current study follow-up period was short (1 month), results from similar studies showed that the improvement in eye drop administration skills was sustainable for at least 1 year after the end of the educational sessions.[21] Furthermore, the benefit from the current educational program was not found to be significantly affected by the participants’ demographics like age and educational level. This was in contrast with the findings of Muir et al. who reported that educational interventions are more likely to be beneficial for patients with limited literacy.[30] Moreover, the current study results showed a nonsignificant effect of participant’s clinical parameters (i.e., medication adherence, accuracy of administering eye drops, number of used eye drops, and duration of glaucoma) on the degree of benefit received from the educational program. This finding was in contrast with a study conducted in Saudi Arabia which found a strong correlation between glaucoma duration and the level of medication adherence with the benefit from educational interventions.[11] Meanwhile, the current study finding means that all enrolled glaucoma patients without regard to their demographics and basic clinical parameters can get a significant benefit from pharmacist-led education.

The aforementioned conclusion could be attributed to the fact that nearly all study participants (as shown in study results) did not receive an education about anti-glaucoma medications previously; this serious issue raises a red flag about the role of pharmacists in educating glaucoma patients about their medications. Similarly, other studies conducted in Iraq found a very limited role of pharmacists in educating patients about their medications.[731]

The primary limitation of this study was the small sample size, largely due to a high dropout rate. While there was no significant difference in the demographic and clinical parameters between participants who completed the study and those who dropped out, suggesting that the dropout was not related to the study design or educational program, this issue warrants further discussion. The high dropout rate may reflect socio-cultural characteristics of Iraqi patients, including limited health literacy, as reported in previous study.[32] This limitation means that the results of the present study should be interpreted cautiously, as the findings might not fully capture the variability present in the broader target population.

In addition, the generalizability of the study’s findings is restricted.

Future research with a more robust design, including the use of a control group, multiple observers to improve the rigor and validity of the findings as well as use of larger sample size to enhance generalizability.

CONCLUSIONS

The current pharmacist-led educational program proved to be a highly effective tool that improved eye drop instillation technique, medication adherence, and the achievement of lOP target within a sample of Iraqi individuals diagnosed with glaucoma. Despite study limitations, these findings are promising and offer valuable insights into the potential benefits of pharmacist-led educational programs for glaucoma management. Further research with more robust designs is expected to build upon these results.

AUTHOR’S CONTRIBUTIONS

Duaa Raad Sadiq: Data collection and writing the first draft. Ehab Mudher Mikhael: Study design, data analysis, and revising the whole manuscript. Ameer Marouf: Data collection.

Conflicts of interest

There are no conflicts of interest.

Related articles

PubMed

Evaluation of Plasma Spermine and Spermidine Levels in Primary Open-Angle Glaucoma and Exfoliation Glaucoma.

Objectives This study aimed to compare plasma spermine and spermidine concentrations in patients with primary open-angle glaucoma (POAG), patients with exfoliation glaucoma (EG), and healthy individuals, and to explore their potential association with disease severity. Materials and Methods This prospective case-control study was conducted at a tertiary referral center and included patients with an established diagnosis of POAG or EG for more than two years. The control group consisted of age...

PubMed

Twelve-Month Efficacy and Tolerability of Netarsudil 0.02% in Korean Patients with Primary Open-Angle Glaucoma and Normal-Tension Glaucoma: A Single-Center Retrospective Study.

Purpose The 12-month intraocular pressure (IOP)-lowering efficacy and tolerability of netarsudil 0.02%, a Rho-kinase inhibitor, were evaluated in Korean patients with primary open-angle glaucoma (POAG), including normal-tension glaucoma (NTG). Methods Eighty-six patients (131 eyes) starting netarsudil at one center in November 2024–February 2025 were reviewed; entry required 3 months of follow-up, continued to 12 months. IOP was measured by Goldmann applanation tonometry at baseline and 1, 3,...